The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones.
about
Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal womenNTP-CERHR expert panel report on the reproductive and developmental toxicity of soy formulaEquol: pharmacokinetics and biological actionsEquol: history, chemistry, and formationThe chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancerThe pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracersA preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and womenInfluences of dietary soy isoflavones on metabolism but not nociception and stress hormone responses in ovariectomized female rats.Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial.The impact of equol-producing status in modifying the effect of soya isoflavones on risk factors for CHD: a systematic review of randomised controlled trialsThe Reciprocal Interactions between Polyphenols and Gut Microbiota and Effects on BioaccessibilityVitamin D interactions with soy isoflavones on bone after menopause: a reviewDietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseasesFlavonoid bioavailability and attempts for bioavailability enhancementLactulose increases equol production and improves liver antioxidant status in barrows treated with DaidzeinOrganization of GC/MS and LC/MS metabolomics data into chemical librariesSoy and Health Update: Evaluation of the Clinical and Epidemiologic LiteratureThe role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoidsThe role of colonic bacteria in the metabolism of the natural isoflavone daidzin to equolIsoflavones and PPAR Signaling: A Critical Target in Cardiovascular, Metastatic, and Metabolic DiseaseThe pros and cons of phytoestrogensSoy but not bisphenol A (BPA) induces hallmarks of polycystic ovary syndrome (PCOS) and related metabolic co-morbidities in ratsAVPV neurons containing estrogen receptor-beta in adult male rats are influenced by soy isoflavones.Isolation of a human intestinal bacterium capable of daidzein and genistein conversionDevelopmental and Reproductive Effects of SE5-OH: An Equol-Rich Soy-Based Ingredient.Dose-response assessment of the anti-cancer efficacy of soy isoflavones in dimethylhydrazine-treated rats fed 6% fructooligosaccharideS-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.The safety and tolerance of phytotherapies in menopausal medicine - a review of the literatureInfluence of sex hormones and phytoestrogens on heart disease in men and womenTesticular development in male rats is sensitive to a soy-based diet in the neonatal period.Flavonoids, Thyroid Iodide Uptake and Thyroid Cancer-A Review.Urinary isoflavone concentrations are inversely associated with cardiometabolic risk markers in pregnant U.S. womenBioavailability of the polyphenols: status and controversiesFlavonoids and age-related disease: risk, benefits and critical windows.Equol, via dietary sources or intestinal production, may ameliorate estrogen deficiency-induced bone lossGut microbes, diet, and cancer.The metabolism and analysis of isoflavones and other dietary polyphenols in foods and biological systems.Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humansCloning and expression of a novel NADP(H)-dependent daidzein reductase, an enzyme involved in the metabolism of daidzein, from equol-producing Lactococcus strain 20-92.The role of soy in vegetarian diets
P2860
Q21245644-61A4BF73-8282-49BD-92E5-86BADC72B975Q23915889-D3D2F23A-7C69-437F-9B8A-DD2270DBA57BQ24594626-F6819574-937E-4E23-80F4-A59DE3C6612BQ24594674-E81D820B-AC33-4016-BE69-98FBE7D135C1Q24628910-2BFC9CC5-22F5-4DB2-8F87-B3A11CDE3B3CQ24653795-15ACFC2C-92B8-4938-AC05-616394DB3E91Q24657278-9F244C16-56D3-43D4-9670-8E4283401D0BQ24813060-A886BEC8-5351-4CD6-B8BD-3B956BD4611BQ24814372-C960B17C-4464-4F6A-AB8C-9C8220C97DE7Q26740096-B74D66FD-0A02-4CCA-B48F-C0664800D55CQ26767195-AC54F7FD-5A4B-4157-96A4-BF6EE1436852Q26824544-5E16A6A1-91A1-47EA-8D47-276FAC86779FQ27002456-49AE359D-7F76-4F84-A336-FB8BA55F9DD1Q27009155-BBAAC851-B045-4B9B-995B-09EC042D5D86Q27312447-D7966FC9-51DF-458D-88F2-74C33F68A66EQ27702050-A6B095D7-A1F1-4491-8A8A-052FBF133C93Q28071946-EF85A8EB-F172-4E3E-98B7-97DB8FFD1D1DQ28078760-17037E77-2538-4584-8D53-AB27FADA522BQ28087603-3220A5F8-2EB3-4073-BFEE-A26629E67D78Q28387066-B602951D-4650-4A21-BC31-A671657C1F86Q28387746-AFA288B5-6ACE-4A0B-9CF6-540550689400Q28390176-6072AC3E-1069-4C23-83E2-13C0FA4C0EC2Q33271212-41956BA5-E101-4BE6-9754-C07E83358977Q33399380-25542EEE-E967-4B38-A725-464242782A61Q33602879-8646F559-B626-4578-8A97-4BE54A981B2FQ33626196-B2766E3A-FCD5-4704-830B-2C123598BC27Q33641060-BF22F6BE-A098-4D87-B19F-D172B02484F1Q33704848-D46B67F3-B362-4FB5-937D-ABB89AE70C06Q33721061-148DF9EC-CC59-4FD7-8774-D88C36B47ED0Q33826348-7DA1FCD4-E1FC-4A32-941B-C448C8447538Q33838859-1F50EDE1-A0EA-497A-A6E8-4D14CBCB1835Q33851053-5D1780C0-6AF4-4640-94C5-7CAF589BEE8BQ33853845-7DAFDE2F-5501-43BE-8445-1ADCFF8A3F29Q33889019-9CD12B32-0AA7-421D-9342-D1B4DCA5642EQ33908748-D33C77EF-E22D-4FE1-BA9C-C3C07C8541DFQ34000541-38E409FB-0B03-4C01-B1F0-FD24BBC60158Q34005314-4A87501A-BFBF-4B2B-96B6-481EA24DD410Q34097864-4BE3F78F-8476-4EBF-B548-996A332D5718Q34108905-EE48F3BB-06C2-4A95-923A-6D079C91A861Q34247970-11291CC1-5C87-41B3-959B-DE84CE2E979A
P2860
The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The clinical importance of the ...... ss of soy and its isoflavones.
@ast
The clinical importance of the ...... ss of soy and its isoflavones.
@en
The clinical importance of the ...... ss of soy and its isoflavones.
@nl
type
label
The clinical importance of the ...... ss of soy and its isoflavones.
@ast
The clinical importance of the ...... ss of soy and its isoflavones.
@en
The clinical importance of the ...... ss of soy and its isoflavones.
@nl
prefLabel
The clinical importance of the ...... ss of soy and its isoflavones.
@ast
The clinical importance of the ...... ss of soy and its isoflavones.
@en
The clinical importance of the ...... ss of soy and its isoflavones.
@nl
P2093
P356
P1433
P1476
The clinical importance of the ...... ss of soy and its isoflavones.
@en
P2093
Eva Lydeking-Olsen
Kenneth D R Setchell
Nadine M Brown
P304
P356
10.1093/JN/132.12.3577
P407
P577
2002-12-01T00:00:00Z